Lee YK, Kuo HC. Effectiveness of Platelet-Rich Plasma Injections as Prophylaxis for Recurrent Urinary Tract Infection in Women. J Clin Med. 2023 Jun 19;12(12):4129. doi: 10.3390/jcm12124129. PMID: 37373821; PMCID: PMC10299700.
Lee YK, Jiang YH, Jhang JF, Ho HC, Kuo HC. Changes in the Ultrastructure of the Bladder Urothelium in Patients with Interstitial Cystitis after Intravesical Injections of Platelet-Rich Plasma. Biomedicines. 2022 May 20;10(5):1182. doi: 10.3390/biomedicines10051182. PMID: 35625918; PMCID: PMC9138714.
Lee YK, Jhang JF, Jiang YH, Hsu YH, Ho HC, Kuo HC. Difference in electron microscopic findings among interstitial cystitis/bladder pain syndrome with distinct clinical and cystoscopic characteristics. Sci Rep. 2021 Aug 26;11(1):17258. doi: 10.1038/s41598-021-96810-w. PMID: 34446784; PMCID: PMC8390653.
Lee YK, Kuo HC. Therapeutic Effects of Botulinum Toxin A, via Urethral Sphincter Injection on Voiding Dysfunction Due to Different Bladder and Urethral Sphincter Dysfunctions. Toxins (Basel). 2019 Aug 23;11(9):487. doi: 10.3390/toxins11090487. PMID: 31450851; PMCID: PMC6784014.
Lee YK, Kuo HC. Safety and therapeutic efficacy of mirabegron 25 mg in older patients with overactive bladder and multiple comorbidities. Geriatr Gerontol Int. 2018 Sep;18(9):1330-1333. doi: 10.1111/ggi.13465. Epub 2018 Jun 21. PMID: 29931793.
Lee YK, Jhang JF, Kuo HC. Clinical Outcome of Augmentation Enterocystoplasty for Patients with Ketamine-induced Cystitis. Pain Physician. 2017 Mar;20(3):E431-E436. PMID: 28339443.
Chen YT, Yeh HC, Lee HY, Hsieh PF, Chou EC, Tsai YC, Hong JH, Huang CY, Jiang YH, Lee YK, Tseng JS, Yu CC, Chiang BJ, Hsueh TY, Wu CC, Tsai CY. Endoscopic management of upper tract urothelial cancer in a highly endemic area: A Taiwan nationwide collaborative study. Asian J Surg. 2023 Aug;46(8):3058-3065. doi: 10.1016/j.asjsur.2022.10.046. Epub 2022 Oct 29. PMID: 37525448.
Yu CC, Chang CH, Fang JK, Huang SK, Tseng WH, Lee HY, Yeh HC, Chen IA, Lin JT, Chen PC, Cheong IS, Hsueh TY, Jiang YH, Lee YK, Chen WC, Lo SH, Lin PH, Wang SS, Huang CY, Wu CC, Tseng JS, Wu SY, Tsai YC. Impact of pathological response on oncological outcomes in patients with upper tract urothelial cancer receiving neo-adjuvant chemotherapy. J Formos Med Assoc. 2023 Dec;122(12):1274-1281. doi: 10.1016/j.jfma.2023.06.003. Epub 2023 Jul 1. PMID: 37400294.
Chen WH, Lee YK, Kuo HC, Wang JH, Jiang YH. Oncological and functional outcomes of high-risk and very high-risk prostate cancer patients after robot-assisted radical prostatectomy. PLoS One. 2023 Mar 3;18(3):e0282494. doi: 10.1371/journal.pone.0282494. PMID: 36867638; PMCID: PMC9983825.
Cheng PY, Lee HY, Li WM, Huang SK, Liu CL, Chen IA, Lin JT, Lo CW, Yu CC, Wang SS, Chen CS, Tseng JS, Lin WR, Yeong-Chin J, Cheong IS, Jiang YH, Lee YK, Chen YT, Chen SH, Chiang BJ, Hsueh TY, Huang CY, Wu CC, Lin WY, Tsai YC, Yu KJ, Huang CP, Huang YY, Tsai CY. Preoperative hydronephrosis is an independent protective factor of renal function decline after nephroureterectomy for upper tract urothelial carcinoma. Front Oncol. 2023 Feb 24;13:944321. doi: 10.3389/fonc.2023.944321. PMID: 36910617; PMCID: PMC9998910.
Wu KH, Chang CH, Wu HC, Huang SK, Liu CL, Yang CK, Li JR, Tseng JS, Lin WR, Yu CC, Lo CW, Huang CY, Chen CH, Tsai CY, Cheng PY, Jiang YH, Lee YK, Chen YT, Yeh TC, Lin JT, Tsai YC, Hsueh TY, Chiang BJ, Chiang YD, Lin WY, Jou YC, Pang ST, Ke HL. Oncologic impact of delay between diagnosis and radical nephroureterectomy. Front Oncol. 2022 Dec 14;12:1025668. doi: 10.3389/fonc.2022.1025668. PMID: 36591462; PMCID: PMC9795168.
Chen SF, Lee YK, Kuo HC. Satisfaction with Urinary Incontinence Treatments in Patients with Chronic Spinal Cord Injury. J Clin Med. 2022 Oct 4;11(19):5864. doi: 10.3390/jcm11195864. PMID: 36233731; PMCID: PMC9571409.
Lee HY, Chang CH, Huang CP, Yu CC, Lo CW, Chung SD, Wu WC, Chen IA, Lin JT, Jiang YH, Lee YK, Hsueh TY, Chiu AW, Chen YT, Lin CM, Tsai YC, Chen WC, Chiang BJ, Huang HC, Chen CH, Huang CY, Wu CC, Lin WY, Tseng JS, Ke HL, Yeh HC. Is Lymph Node Dissection Necessary During Radical Nephroureterectomy for Clinically Node-Negative Upper Tract Urothelial Carcinoma? A Multi-Institutional Study. Front Oncol. 2022 Apr 29;12:791620. doi: 10.3389/fonc.2022.791620. PMID: 35574295; PMCID: PMC9099435.
Lo CW, Li WM, Ke HL, Chang YH, Wu HC, Chen IA, Lin JT, Huang CY, Chen CH, Tseng JS, Lin WR, Jiang YH, Lee YK, Tsai CY, Chung SD, Hsueh TY, Chiu AW, Jou YC, Cheong IS, Chen YT, Chen JS, Chiang BJ, Yu CC, Lin WY, Wu CC, Chen CS, Weng HY, Tsai YC. Impact of Adjuvant Chemotherapy on Variant Histology of Upper Tract Urothelial Carcinoma: A Propensity Score-Matched Cohort Analysis. Front Oncol. 2022 Apr 22;12:843715. doi: 10.3389/fonc.2022.843715. PMID: 35530335; PMCID: PMC9072967.
Jiang YH, Jhang JF, Lee YK, Kuo HC. Low-Energy Shock Wave Plus Intravesical Instillation of Botulinum Toxin A for Interstitial Cystitis/Bladder Pain Syndrome: Pathophysiology and Preliminary Result of a Novel Minimally Invasive Treatment. Biomedicines. 2022 Feb 7;10(2):396. doi: 10.3390/biomedicines10020396. PMID: 35203604; PMCID: PMC8962423.
Lin CY, Weng HY, Tai TY, Wu HC, Chen WC, Chen CH, Huang CY, Lo CW, Yu CC, Tsai CY, Wu WC, Jiang YH, Lee YK, Hsueh TY, Chiu AW, Chiang BJ, Huang HC, Chen IA, Chen YT, Lin WY, Wu CC, Tsai YC, Lee HY, Li WM. Clinical Efficacy of Adjuvant Chemotherapy in Advanced Upper Tract Urothelial Carcinoma (pT3-T4): Real-World Data from the Taiwan Upper Tract Urothelial Carcinoma Collaboration Group. J Pers Med. 2022 Feb 6;12(2):226. doi: 10.3390/jpm12020226. PMID: 35207714; PMCID: PMC8877034.
Chen IA, Chang CH, Huang CP, Wu WJ, Li CC, Chen CH, Huang CY, Lo CW, Yu CC, Tsai CY, Wu WC, Tseng JS, Lin WR, Jiang YH, Lee YK, Jou YC, Cheong IS, Hsueh TY, Chiu AW, Chen YT, Chen JS, Chiang BJ, Tsai YC, Lin WY, Wu CC, Lin JT, Yu CC. Factors Predicting Oncological Outcomes of Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma in Taiwan. Front Oncol. 2022 Jan 13;11:766576. doi: 10.3389/fonc.2021.766576. PMID: 35096575; PMCID: PMC8793058.
Chang CH, Wu WJ, Lee HY, Lin CH, Yue CT, Jiang YH, Lee YK, Huang KH, Tsai YC. Impact of Pathology Review in Adverse Histological Characteristics and pT Stages of Upper Tract Urothelial Cancer in a Multicenter Study. Front Oncol. 2021 Nov 25;11:757359. doi: 10.3389/fonc.2021.757359. PMID: 34900706; PMCID: PMC8655678.
Chen YT, Yu CC, Yeh HC, Lee HY, Jiang YH, Lee YK, Kuei CH, Wu CC, Huang CY, Lin WY, Yang CK, Tsai YC. Endoscopic management versus radical nephroureterectomy for localized upper tract urothelial carcinoma in a high endemic region. Sci Rep. 2021 Feb 17;11(1):4040. doi: 10.1038/s41598-021-83495-4. PMID: 33597574; PMCID: PMC7889610.
Yu LC, Chang CH, Huang CP, Huang CY, Hong JH, Tai TY, Weng HY, Lo CW, Tsai CY, Lee YK, Tsai YC, Hsueh TY, Chen YT, Chen IH, Chiang BJ, Tseng JS, Wu CC, Lin WY, Chien TM, Sheu ZL, Li CC, Ke HL, Li WM, Lee HY, Wu WJ, Yeh HC. Prognostic Significance of Primary Tumor Location in Upper Tract Urothelial Carcinoma Treated with Nephroureterectomy: A Retrospective, Multi-Center Cohort Study in Taiwan. J Clin Med. 2020 Nov 27;9(12):3866. doi: 10.3390/jcm9123866. PMID: 33261187; PMCID: PMC7761410.
